ARTICLE | Company News
Paion GmbH, Nippon Shinyaku Co. Ltd deal
October 11, 2004 7:00 AM UTC
Paion received an exclusive worldwide license outside of Japan to develop and market Nippon Shinyaku's Enecadin (NS-7), a neuroprotective agent. The compound has completed some Phase II trials, and Pa...